HighTower Advisors LLC Boosts Stock Position in ProPhase Labs, Inc. (NASDAQ:PRPH)

HighTower Advisors LLC boosted its holdings in shares of ProPhase Labs, Inc. (NASDAQ:PRPH) by 18.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 179,045 shares of the company’s stock after purchasing an additional 27,673 shares during the period. HighTower Advisors LLC owned about 0.75% of ProPhase Labs worth $434,000 at the end of the most recent reporting period.

ProPhase Labs Stock Down 6.5 %

Shares of ProPhase Labs stock opened at $0.61 on Friday. The company’s fifty day simple moving average is $1.31 and its two-hundred day simple moving average is $2.48. The company has a market cap of $14.58 million, a P/E ratio of -0.48 and a beta of -0.32. The company has a current ratio of 1.47, a quick ratio of 1.33 and a debt-to-equity ratio of 0.48. ProPhase Labs, Inc. has a 12-month low of $0.61 and a 12-month high of $7.48.

ProPhase Labs Profile

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.